Literature DB >> 24461424

Putting value in biomarker research and reporting.

Harald Mischak1, Antonia Vlahou2, Pier Giorgio Righetti3, Juan J Calvete4.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24461424     DOI： 10.1016/j.jprot.2013.12.002

Source DB:  PubMed          Journal:  J Proteomics        ISSN： 1874-3919            Impact factor:   4.044


× No keyword cloud information.
  7 in total

Review 1.  Proteomic biomarkers in kidney disease: issues in development and implementation.

Authors:  Harald Mischak; Christian Delles; Antonia Vlahou; Raymond Vanholder
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

Review 2.  Developing proteomic biomarkers for bladder cancer: towards clinical application.

Authors:  Maria Frantzi; Agnieszka Latosinska; Leif Flühe; Marie C Hupe; Elena Critselis; Mario W Kramer; Axel S Merseburger; Harald Mischak; Antonia Vlahou
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

Review 3.  Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases.

Authors:  Pedro Magalhães; Harald Mischak; Petra Zürbig
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

Review 4.  Biomarker discovery in mass spectrometry-based urinary proteomics.

Authors:  Samuel Thomas; Ling Hao; William A Ricke; Lingjun Li
Journal:  Proteomics Clin Appl       Date:  2016-02-11       Impact factor: 3.494

5.  Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.

Authors:  Maria Frantzi; Akshay Bhat; Agnieszka Latosinska
Journal:  Clin Transl Med       Date:  2014-03-29

6.  Do fragments and glycosylated isoforms of alpha-1-antitrypsin in CSF mirror spinal pathophysiological mechanisms in chronic peripheral neuropathic pain? An exploratory, discovery phase study.

Authors:  Emmanuel Bäckryd; Sofia Edström; Björn Gerdle; Bijar Ghafouri
Journal:  BMC Neurol       Date:  2018-08-16       Impact factor: 2.474

7.  Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.

Authors:  Esther Nkuipou-Kenfack; Flore Duranton; Nathalie Gayrard; Àngel Argilés; Ulrika Lundin; Klaus M Weinberger; Mohammed Dakna; Christian Delles; William Mullen; Holger Husi; Julie Klein; Thomas Koeck; Petra Zürbig; Harald Mischak
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.